Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

February 2026

AI-Driven Identification of Actionable NSCLC Biomarkers

2026-02-06T10:45:36+00:00

Imagene's multi-center retrospective study on AI-driven identification of actionable NSCLC biomarkers is now published in npj PrecisionOncology (Nature Portfolio). Although biomarker testing is central to modern cancer care, real-world practice often falls short of enabling optimal, personalized treatment planning. Importantly, treatment pathways rely not only on detecting driver alterations, but also on confidently identifying when such [...]

AI-Driven Identification of Actionable NSCLC Biomarkers2026-02-06T10:45:36+00:00

Illumina Completes Acquisition of SomaLogic

2026-02-06T09:44:37+00:00

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis  Combination leverages SomaScan with Illumina's NGS ecosystem, DRAGEN software, and Illumina Connected Multiomics to rapidly transform insights into discoveries Illumina, Inc. today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The highly [...]

Illumina Completes Acquisition of SomaLogic2026-02-06T09:44:37+00:00

Lilian Greenwood MP Visits AXREM Member Source LDPath to Explore Cutting‑Edge Genomics and Histopathology Services

2026-02-04T14:40:29+00:00

AXREM, the UK trade association representing suppliers of imaging and radiotherapy equipment and services, recently facilitated a visit by Lilian Greenwood, MP for Nottingham South and Parliamentary Under‑Secretary of State for Local Transport, to AXREM member Source LDPath at their Nottingham headquarters. The visit provided an opportunity for the MP to gain first‑hand insight into the [...]

Lilian Greenwood MP Visits AXREM Member Source LDPath to Explore Cutting‑Edge Genomics and Histopathology Services2026-02-04T14:40:29+00:00

Case of the Month – February 2026 – Case of Nasal Feline Leprosy in a Six-Year-Old Ragdoll Cat

2026-02-06T11:43:06+00:00

Author: Sofia Clara Sacco DVM, PhD Case presentation A six-year-old female Ragdoll cat was examined at a veterinary clinic for a nasal mass. A biopsy measuring 1 cm was performed and submitted to NationWide Laboratories for histopathological evaluation. Histological findings The connective tissue of the lamina propria of the nasal cavity was effaced by a [...]

Case of the Month – February 2026 – Case of Nasal Feline Leprosy in a Six-Year-Old Ragdoll Cat2026-02-06T11:43:06+00:00

Digital Pathology Transformation: Expert Insights on Navigating the Future of Diagnostic Practice

2026-02-02T10:01:25+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  In an interview with Pathology News, Catarina Eloy, MD, PhD, lead author of the European Society of Pathology (ESP)’s expert opinion paper on digital pathology transformation, discussed with us how the shift to digital workflows is reshaping pathology practice and patient care.  Pathology Transformation in Europe Dr. Eloy explained that [...]

Digital Pathology Transformation: Expert Insights on Navigating the Future of Diagnostic Practice2026-02-02T10:01:25+00:00

Aiforia Releases a New CE-IVD Marked AI Solution for Gastric Cancer Diagnostics

2026-10-06T08:45:57+00:00

Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is designed to support pathologists in the detection and reporting of gastric cancer in digitized gastric tissue samples. Gastric cancer is one of the leading causes of cancer-related [...]

Aiforia Releases a New CE-IVD Marked AI Solution for Gastric Cancer Diagnostics2026-10-06T08:45:57+00:00

Hartford HealthCare Cancer Institute Becomes First Health System in the Nation Designated as MSK Care Partner

2026-02-05T11:55:33+00:00

Hartford HealthCare Cancer Institute has achieved a historic milestone by becoming the first healthcare system in the U.S to be designated as a Care Partner of Memorial Sloan Kettering Cancer Center (MSK Care Partner). This designation follows a rigorous review process by MSK to ensure that oncology care across the Hartford HealthCare Cancer Institute meets MSK Standards of Care™. [...]

Hartford HealthCare Cancer Institute Becomes First Health System in the Nation Designated as MSK Care Partner2026-02-05T11:55:33+00:00

Five Collaboration Trends That Shaped Healthcare AI in 2025

2026-02-04T09:12:56+00:00

Relationships between health systems, non profits, universities and public agencies are not new. The difference here is a nuance, the structure of the relationships are what stands out in these collaborations. The recent Mayo Clinic announcement caught my attention for reasons that run deep. I am a breast cancer survivor who remembers how much depends on timely [...]

Five Collaboration Trends That Shaped Healthcare AI in 20252026-02-04T09:12:56+00:00

January 2026

Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology-Healthcare Informatics

2026-02-04T09:01:39+00:00

Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics Frost & Sullivan is pleased to announce that Philips has been awarded the 2025 Global Enabling Technology Leadership Recognition in the Digital Pathology–Healthcare Informatics sector for its outstanding achievements in delivering next-generation digital pathology innovation, accelerated workflow modernization, and [...]

Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology-Healthcare Informatics2026-02-04T09:01:39+00:00

CAP Highlights Molecular Testing in Complex Cancer Diagnoses

2026-02-02T10:23:54+00:00

For patients with cancers of unknown primary (CUP) and other diagnostically ambiguous tumors, molecular testing may help pathologists identify tumor origin and guide targeted treatment decisions, according to a new article from the College of American Pathologists (CAP). In “Utility of Molecular Testing in the Diagnostic Workup of Difficult-to-Classify Tumors,” authors Jie-Fu Chen, MD, FCAP, Personalized [...]

CAP Highlights Molecular Testing in Complex Cancer Diagnoses2026-02-02T10:23:54+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top